Hi-Tech Pharmacal Overview

  • Founded

  • 1982

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 805

Employees
  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 1

  • Investments

  • 3

Hi-Tech Pharmacal General Information

Description

Manufacturer of pharmaceutical products. The company offers pharmaceutical products, branded prescription products and branded over-the-counter products for the diabetes, pain and allergy. It also manufactures over-the-counter generic drugs in liquid and semi-solid dosage forms.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Parent Company
Akorn
Primary Office
  • 369 Bayview Avenue
  • Amityville, NY 11701
  • United States
+1 (631) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hi-Tech Pharmacal Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hi-Tech Pharmacal‘s full profile, request access.

Request a free trial

Hi-Tech Pharmacal Patents

  • 6

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Hi-Tech Pharmacal Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9301988-B2 Method of treatment using a therapeutic agent for intranasal administration Active 21-Oct-2010 000000000
US-20130115320-A1 Therapeutic agent for intranasal administration and method of making and using same Abandoned 21-Oct-2010 000000000
US-20140356465-A1 Method of treatment using a therapeutic agent for intranasal administration Granted 21-Oct-2010 000000000
US-8900643-B2 Method of treatment using a therapeutic agent for intranasal administration Active 21-Oct-2010 000000000
US-20130115321-A1 Therapeutic agent for intranasal administration and method of making and using same Abandoned 21-Oct-2010 A61K36/81
To view Hi-Tech Pharmacal’s complete patent history, request access »

Hi-Tech Pharmacal Executive Team (4)

Name Title Board Seat Contact Info
David Seltzer Chief Executive Officer, President & Chairman
Reuben Seltzer Vice Chairman
You’re viewing 2 of 4 executive team members. Get the full list »

Hi-Tech Pharmacal Board Members (6)

Name Representing Role Since
0000000 0000000 Self Board Member 000 0000
00000 0000000 Self Board Member 000 0000
0000 00000000 Self Board Member 000 0000
000000 0000000 00 Tashlik Goldwyn Levy Board Member 000 0000
000000 0000000 Hi-Tech Pharmacal Vice Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Hi-Tech Pharmacal Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hi-Tech Pharmacal Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000 18-Jan-2012 000000000 Buildings and Property 00000 000
0. 000000000 02-Mar-2009 0000000000 00.00 Drug Discovery 00000 000
Midlothian Laboratories 31-Dec-2007 Merger/Acquisition 000 Pharmaceuticals 00000 000
To view Hi-Tech Pharmacal’s complete investments and acquisitions history, request access »

Hi-Tech Pharmacal Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0. 000000000 00000 02-Mar-2009 000000000000000000 00.00 Completed
  • 00-0000 000000000
Midlothian Laboratories 31-Dec-2007 Merger/Acquisition 000 Completed
To view Hi-Tech Pharmacal’s complete exits history, request access »